Tag: Biotechnology

Boomray Pharmaceuticals enters into an exclusive global licence agreement valued at up to USD900 million with Novartis for a preclinical radioligand therapy

Hong Kong lawyers examine the opportunities and challenges facing the city’s ambition to become a regional intellectual property trading centre

Pharmaceutical giant GSK enters into an asset purchase agreement with Chimagen Biosciences valued at up to USD750 million

Loeb & Loeb expands its global presence with the launch of a Singapore office 

Ingenia Therapeutics’ KRW60 billion (USD42.4 million) IPO to become first listing of a US-based company in Korea

How can companies identify the right lawyer? A China Business Law Journal survey reveals what factors are truly driving the choices of general counsel

HKEX sharpens 18A review, prioritising verifiable product development chains

Han Kun appoints former AstraZeneca associate legal director Wang Rongxia as patent counsel in its Beijing office

Philippines law firm Ocampo & Suralvo Law Office strengthens corporate and M&A team with partner Lyra Flores-Bisnar’s arrival

Allen & Gledhill appoints Wang Xin partner to lead China practice in Shanghai, strengthening M&A

Simpson Thacher advises Japan’s Sumitomo Pharma on its USD711m international share offering

Biosimilars, biologics and patents: High Court decisions reshape claim mapping, discovery and injunctions in India

Sidley Austin advises Australia-based Telix Pharmaceuticals on its USD2.1 billion strategic collaboration with American biotech Regeneron

Market reforms, investor activity and fundraising trends highlight the investment ecosystems in Hong Kong and Taiwan

Growth Drivers: We highlight leading Chinese and international lawyers who excel across legal and business sectors

JSA advised Torreya Holdings in the 100% acquisition of Torreya Partners by Stifel Financial Corp for an undisclosed amount